HX4-25889-85868

2 vaccinations 1 coded response 1 check-in 0 free-text entries 0 call cases

Sex: Male
Age at first dose: 0-4
ZIP prefix: 111 / NY
Registered: 2023-03-22

Relationship: Child or adolescent in my care
Guardian: VSC-21880-04682
Race: Multiracial
Ethnicity: Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-12-12
Dose 1 — Moderna
Co-administered: Flu:Hepatitis B:Pneumonia:Polio:Rotavirus:Tetanus
2023-01-12
Dose 2 — Moderna
Co-administered: Flu
2023-03-22
Registered in v-safe
2023-04-13
Survey response — 3 months, dose 2, under 3
MedDRA: Nasopharyngitis — Feeling: Good

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-12-12	Moderna	Flu:Hepatitis B:Pneumonia:Polio:Rotavirus:Tetanus
2	2023-01-12	Moderna	Flu

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release